Home > Publications database > Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma. |
Journal Article | DKFZ-2018-00223 |
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
2014
Cell Press
Cambridge, Mass.
This record in other databases:
Please use a persistent id in citations: doi:10.1016/j.ccr.2014.05.005
Abstract: Functional heterogeneity within tumors presents a significant therapeutic challenge. Here we show that quiescent, therapy-resistant Sox2(+) cells propagate sonic hedgehog subgroup medulloblastoma by a mechanism that mirrors a neurogenic program. Rare Sox2(+) cells produce rapidly cycling doublecortin(+) progenitors that, together with their postmitotic progeny expressing NeuN, comprise tumor bulk. Sox2(+) cells are enriched following anti-mitotic chemotherapy and Smoothened inhibition, creating a reservoir for tumor regrowth. Lineage traces from Sox2(+) cells increase following treatment, suggesting that this population is responsible for relapse. Targeting Sox2(+) cells with the antineoplastic mithramycin abrogated tumor growth. Addressing functional heterogeneity and eliminating Sox2(+) cells presents a promising therapeutic paradigm for treatment of sonic hedgehog subgroup medulloblastoma.
Keyword(s): Antigens, Nuclear ; Antineoplastic Agents ; Biomarkers, Tumor ; Hedgehog Proteins ; Microtubule-Associated Proteins ; Nerve Tissue Proteins ; NeuN protein, mouse ; Neuropeptides ; Nuclear Proteins ; Patched Receptors ; Receptors, Cell Surface ; Receptors, G-Protein-Coupled ; SHH protein, human ; SMO protein, human ; SOX2 protein, human ; SOXB1 Transcription Factors ; Shh protein, mouse ; Smo protein, mouse ; Smoothened Receptor ; Sox2 protein, mouse ; doublecortin protein ; neuronal nuclear antigen NeuN, human ; Plicamycin
![]() |
The record appears in these collections: |